Elan was founded in 1969 by Donald E. Panoz and incorporated in Ireland. In 1972, Elan's first drug delivery product, tetracycline, was launched in the UK. In 1981, Elan Pharmaceutical Research was formed. Headquartered in Gainesville, Georgia, it floated on the NASDAQ exchange in 1982. Elan conducts its worldwide business, including operations relating to research and development, manufacturing and marketing, through wholly-owned subsidiaries incorporated in Ireland, the United States, the United Kingdom and other countries in which it conducts business.
R&D
To view this information, you must subscribe to Partneringtools.
Partnerships
To view this information, you must subscribe to Partneringtools.
Deals
To view this information, you must subscribe to Partneringtools.
Latest News
To view this information, you must subscribe to Partneringtools.
Senior management
To view this information, you must subscribe to Partneringtools.
Board of directors
To view this information, you must subscribe to Partneringtools.
Head office
To view this information, you must subscribe to Partneringtools.
Regional and subsidiary offices
To view this information, you must subscribe to Partneringtools.